Form 4 for NAGE Niagen Bioscience, Inc.
Accepted 2022-10-03 00:00:00 ET · period of report 2022-09-30 · accession 0001628280-22-025915 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-03 | 2022-09-30 | NAGE | Fried Robert N | Cheif Executive Off, Dir | P - Purchase | $1.25 | +80.0K | 972.3K | +9% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-30 | P | A | 80,000 | $1.25 | 972,314 | D | — | — |